Literature DB >> 14675414

Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients.

Nikolaos C Giannakoulas1, Marina Karakantza, Georgios L Theodorou, Maria Pagoni, Athanasios Galanopoulos, Theodora Kakagianni, Alexandra Kouraklis-Symeonidis, Panagiota Matsouka, Alice Maniatis, Nicholas C Zoumbos.   

Abstract

Immune dysfunction, which leads to the suppression of haemopoiesis by cytokines that are secreted by activated T lymphocytes, is considered to play a key role in the pathogenesis of acquired aplastic anaemia (AAA). We investigated the intracytoplasmic expression of type-1 [interferon gamma (IFN-gamma), interleukin (IL)-2] and type-2 (IL-4, IL-10) cytokines in CD4+ and CD8+ T cells before and after in vitro activation in 16 patients with AAA and 17 normal controls. Untreated or refractory patients had a significantly higher proportion of unstimulated CD4+ and CD8+ T cells that produced IFN-gamma and IL-2 whereas the IL-4 and IL-10 producing T cells did not differ from that of controls, resulting in a shift of IFN-gamma/IL-4 ratio towards a type-1 response. Patients in remission had also increased proportion of IFN-gamma-producing unstimulated CD4+ and CD8+ cells, with a parallel rise of IL-4- and IL-10-producing cells and normal IFN-gamma/IL-4 ratio. These data indicate that, in newly diagnosed and refractory patients with AAA, CD4+ cells are polarized towards a type-1 response that in turn leads to activation of cytotoxic CD8+ cells and finally to haemopoietic stem cell destruction. The type-1 response persists in patients in remission although this effect is compensated by the increase of IL-4 and IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675414     DOI: 10.1046/j.1365-2141.2003.04729.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.

Authors:  Andrew J Erie; Leigh Samsel; Tomoiku Takaku; Marie J Desierto; Keyvan Keyvanfar; J Philip McCoy; Neal S Young; Jichun Chen
Journal:  Exp Hematol       Date:  2011-05-13       Impact factor: 3.084

2.  T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia.

Authors:  Elena E Solomou; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

3.  Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.

Authors:  Feng Zhu; Jianlin Qiao; Xiao-min Zhong; Qing-yun Wu; Wei Chen; Yao Yao; Ming-shan Niu; Chun-ling Fu; Ling-yu Zeng; Zhen-yu Li; Kai-lin Xu
Journal:  Med Oncol       Date:  2015-06-07       Impact factor: 3.064

4.  Expression of IL-27, Th1 and Th17 in patients with aplastic anemia.

Authors:  Hui-zhen Du; Qian Wang; Jian Ji; Bao-ming Shen; Shao-chun Wei; Li-juan Liu; Juan Ding; Dao-xin Ma; Wen Wang; Jun Peng; Ming Hou
Journal:  J Clin Immunol       Date:  2012-09-30       Impact factor: 8.317

Review 5.  The complex pathophysiology of acquired aplastic anaemia.

Authors:  Y Zeng; E Katsanis
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

6.  Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.

Authors:  Zhijie Wu; Valentina Giudice; Jichun Chen; Wanling Sun; Zenghua Lin; Keyvan Keyvanfar; Nidhi Talasani; Sachiko Kajigaya; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-10-12       Impact factor: 3.084

7.  Th17 immune responses contribute to the pathophysiology of aplastic anemia.

Authors:  Regis Peffault de Latour; Valeria Visconte; Tomoiku Takaku; Colin Wu; Andrew J Erie; Annahita K Sarcon; Marie J Desierto; Phillip Scheinberg; Keyvan Keyvanfar; Olga Nunez; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2010-08-23       Impact factor: 22.113

8.  Blood Stem Cell Activity Is Arrested by Th1-Mediated Injury Preventing Engraftment following Nonmyeloablative Conditioning.

Authors:  Antonia M S Müller; Mareike Florek; Holbrook E K Kohrt; Natascha J Küpper; Alexander Filatenkov; Jessica A Linderman; Husein Hadeiba; Robert S Negrin; Judith A Shizuru
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

9.  CD8+ T cells drive autoimmune hematopoietic stem cell dysfunction and bone marrow failure.

Authors:  David M Gravano; Mufadhal Al-Kuhlani; Dan Davini; P Dominick Sanders; Jennifer O Manilay; Katrina K Hoyer
Journal:  J Autoimmun       Date:  2016-07-21       Impact factor: 7.094

10.  Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia.

Authors:  Tomoiku Takaku; Rodrigo T Calado; Sachiko Kajigaya; Neal S Young
Journal:  Ann Hematol       Date:  2009-01-23       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.